Intelligent Investor

Lumos Diagnostics Holdings Limited (ASX: LDX) - Announcements

- Current share price for LDX : $0.049

ASX company news and announcements for Lumos Diagnostics Holdings Limited (LDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Lumos Diagnostics Holdings Limited (LDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Lumos Diagnostics Holdings Limited (LDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Lumos Diagnostics Holdings Limited (LDX)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$24 Lumos quarterly update video interview with CEO, Doug Ward 2 May 2024 2:23PM $0.047 $0.049 $0.055 risen by 4.26%
$24 Notification regarding unquoted securities - LDX 1 May 2024 12:09PM $0.049 $0.049 $0.055 fallen by 0%
$24 Quarterly Activities/Appendix 4C Cash Flow Report 23 Apr 2024 9:10AM $0.056 $0.049 $0.055 fallen by 12.50%
$24 Lumos announces positive FebriDx paediatric study results 8 Apr 2024 9:29AM $0.066 $0.049 $0.055 fallen by 25.76%
$24 Change in substantial holding 2 Apr 2024 5:13PM $0.062 $0.049 $0.055 fallen by 20.97%
$24 Application for quotation of securities - LDX 2 Apr 2024 3:31PM $0.061 $0.049 $0.055 fallen by 19.67%
$24 Section 708A Cleansing Statement 2 Apr 2024 3:29PM $0.061 $0.049 $0.055 fallen by 19.67%
$24 Change in substantial holding 29 Feb 2024 5:50PM $0.072 $0.049 $0.055 fallen by 31.94%
$24 Half Year Results Investor Presentation 28 Feb 2024 8:54AM $0.076 $0.049 $0.055 fallen by 35.53%
$24 Appendix 4D and Half Year Report 28 Feb 2024 8:51AM $0.076 $0.049 $0.055 fallen by 35.53%
$24 1H FY24 Results Investor Briefing Invitation 23 Feb 2024 11:58AM $0.073 $0.049 $0.055 fallen by 32.88%
$24 Change in substantial holding 14 Feb 2024 4:38PM $0.079 $0.049 $0.055 fallen by 37.97%
$24 Lumos Appoints Henry Schein as US Distributor for FebriDx 12 Feb 2024 9:12AM $0.083 $0.049 $0.055 fallen by 40.96%
$24 Lumos Investor Roadshow Presentation 5 Feb 2024 9:55AM $0.079 $0.049 $0.055 fallen by 37.97%
$24 Investor Information Sessions 31 Jan 2024 9:24AM $0.075 $0.049 $0.055 fallen by 34.67%
$24 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2024 9:21AM $0.075 $0.049 $0.055 fallen by 34.67%
$24 Proposed issue of securities - LDX 19 Jan 2024 2:46PM $0.081 $0.049 $0.055 fallen by 39.51%
$24 Notification regarding unquoted securities - LDX 19 Jan 2024 2:42PM $0.081 $0.049 $0.055 fallen by 39.51%
$24 Change in substantial holding 17 Jan 2024 12:00PM $0.084 $0.049 $0.055 fallen by 41.67%
$24 New Hologic Agreements Investor Briefing Presentation 16 Jan 2024 10:35AM $0.085 $0.049 $0.055 fallen by 42.35%
$24 Additional Information Regarding Agreements with Hologic 16 Jan 2024 10:34AM $0.085 $0.049 $0.055 fallen by 42.35%
$24 Notification of cessation of securities - LDX 15 Jan 2024 2:31PM $0.084 $0.049 $0.055 fallen by 41.67%
$24 Investor Briefing on new Hologic Agreements 15 Jan 2024 2:20PM $0.082 $0.049 $0.055 fallen by 40.24%
$24 Lumos Signs Major Development and IP Agreements with Hologic 11 Jan 2024 9:43AM $0.082 $0.049 $0.055 fallen by 40.24%
$24 Change in substantial holding 7 Dec 2023 2:05PM $0.060 $0.049 $0.055 fallen by 18.33%

1 - 25 of 317 results

Page 1 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.